[Cytomegalovirus diagnosis in blood donors and risk patients].
The transfusion transmitted CMV is a possibly dangerous complication of transfusion therapy in immunodeficient patients. We therefore investigated blood donors and patients at increased risk of CMV-infection for CMV-IgG-and-IgM-antibodies. The following CMV IgG and CMV IgM prevalence rates were observed: blood donors 63.7% (0.98%), organ donors 76.9% (0%), patients on hemodialysis 83.0% (17.0%) and drug abusers 57.7% (1.3%). We conclude from our results that CMV IgG testing is useful at every blood donation to provide a large pool of CMV negative blood donors.
Sibrowski
W
W
Abt. für Transfusionsmedizin u. Transplantationsimmunologie, Univ.-Klinik Hamburg.
Kühnl
P
P
Kalmar
G
G
Albert
S
S
Böhm
B O
BO
Doerr
H W
HW
D000914:Antibodies, Viral / Q000032:analysis*; D001782:Blood Donors; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007676:Kidney Failure, Chronic / Q000276:immunology*; D006435:Renal Dialysis; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000276:immunology*; D014019:Tissue Donors
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M
Cytomegalievirus-Diagnostik bei Blutspendern und Risikopatienten.